EKSO BIONICS HOLDINGS, INC. 8-K

What Happened
Ekso Bionics Holdings, Inc. announced that on May 1, 2026 it entered into a Securities Purchase Agreement with Applied Parent (Applied Digital Corporation) to sell 1,311,407 shares of its common stock at $12.01 per share (the April 30, 2026 closing price), for gross proceeds of approximately $15.75 million. The APLD Parent PIPE Investment is described as being “in connection with, and as a condition to Closing,” and the closing of the PIPE is scheduled for 3:01 a.m. ET on May 5, 2026, immediately following the effectiveness of the amended and restated articles. Lake Street Capital Markets served as exclusive placement agent and will receive a cash fee equal to 5.0% of the gross proceeds (about $0.75 million). The Securities Purchase Agreement contains customary representations, warranties, conditions and indemnities; the agreement and closing are disclosed in Exhibit 10.2 to the 8-K.

Key Details

• 1,311,407 common shares to be issued at $12.01 per share for gross proceeds ≈ $15.75 million.
• Closing scheduled for 3:01 a.m. ET on May 5, 2026, immediately after effectiveness of the A&R Articles.
• Placement agent Lake Street Capital Markets fee: 5.0% of gross proceeds (≈ $0.75 million).
• Sale is a private (unregistered) placement; Certificate of Amendment to Articles filed May 1, 2026 (Exhibit 3.1); related agreements are filed or incorporated by reference.

Why It Matters
This transaction provides Ekso with an immediate, material cash infusion (≈ $15.75M) tied to its transaction with Applied Digital, which may support operations or transaction-related requirements. Investors should note the issuance of 1.31M new shares will increase share count (dilution) and net proceeds will be reduced by the placement fee and any other transaction costs. The Securities Purchase Agreement and the filed amendment to the articles of incorporation contain the detailed terms; shareholders can review Exhibits 10.2 and 3.1 in the 8-K for full specifics.